Duty to Innovate? California Supreme Court Questions Novel Product Liability Theory

Start
On May 6, 2026, the California Supreme Court heard oral argument in Gilead Tenofovir Cases, No. S283862, a case that could fundamentally reshape product liability law and the life sciences industry by imposing a “duty to innovate” on pharmaceutical manufacturers….
By: King & Spalding
Previous Story

Prior Concussions Significantly Increase the Risk of Long-Term Disability after a Motor Vehicle Crash

Next Story

Court Overturns $14 Million Judgment Because of Last-Minute Expert Witness Ambush [Sullivan’s Take]